Retour sur lavenir.net
   XIOR 27.100 € (+0,37 %)     VGP 86.800 € (-0,69 %)     VASTNED 29.100 € (-1,36 %)     ASCENCIO 51.500 € (-0,77 %)     SOFINA 230.400 € (-0,09 %)     UCB 254.400 € (-1,97 %)     WHAT'S COOKING GP 145.500 € (0,00 %)     D'IETEREN GROUP 179.900 € (-0,28 %)     WDP 22.020 € (-1,26 %)     AB INBEV 69.460 € (-4,11 %)     ELIA GROUP 138.000 € (-1,43 %)     AZELIS GROUP 9.995 € (+1,11 %)     DECEUNINCK 2.245 € (-1,32 %)     CIE BOIS SAUVAGE 307.000 € (0,00 %)     JENSEN-GROUP 84.000 € (-0,94 %)     SIPEF 90.200 € (-1,85 %)     CENERGY 23.800 € (+3,48 %)     BARCO 8.490 € (-0,35 %)     EVS 27.250 € (-0,91 %)     KBC ANCORA 83.800 € (+0,60 %)     HOME INVEST BE. 19.140 € (-0,31 %)     KBC 121.100 € (+0,37 %)     ENERGYVISION 14.760 € (-0,14 %)     COLRUYT 36.140 € (-0,44 %)     BREDERODE 104.000 € (-0,57 %)     CARE PROPERTY INV. 12.520 € (-0,63 %)     INCLUSIO SA/NV 16.700 € (0,00 %)     MONTEA 67.200 € (-0,44 %)     IBA 17.100 € (-3,39 %)     BEKAERT 40.400 € (-0,62 %)     SOLVAY 26.180 € (-0,68 %)     NYXOAH 1.582 € (-6,94 %)     HYBRID SOFTWARE GR 4.000 € (0,00 %)     MELEXIS 79.400 € (+1,08 %)     SYENSQO 65.350 € (-1,43 %)     VAN DE VELDE 30.000 € (0,00 %)     BIOTALYS 3.040 € (-0,49 %)     AGFA-GEVAERT 0.416 € (-0,95 %)     TESSENDERLO 20.200 € (-0,74 %)     ACKERMANS V.HAAREN 279.200 € (-1,41 %)     PROXIMUS 5.765 € (-2,29 %)     GBL 78.750 € (-0,69 %)     European Medical S 4.900 € (0,00 %)     VIOHALCO 19.280 € (+0,94 %)     ORANGE BELGIUM 21.500 € (0,00 %)     FAGRON 24.250 € (-1,42 %)     ONTEX GROUP 2.380 € (-2,26 %)     BANQUP GROUP 2.070 € (-1,43 %)     LOTUS BAKERIES 11 360.000 € (-3,57 %)     AGEAS 70.700 € (0,00 %)     BPOST 1.660 € (-0,60 %)     RETAIL ESTATES 68.500 € (-0,44 %)     DEME GROUP 174.200 € (-1,80 %)     TITAN S.A. 52.000 € (0,00 %)     CMB.TECH 13.500 € (+2,12 %)     EKOPAK 3.495 € (-1,27 %)     RECTICEL 10.980 € (-0,90 %)     AEDIFICA 69.200 € (-0,72 %)     CAMPINE 222.000 € (+1,83 %)     ARGENX SE 813.000 € (-2,14 %)  
   Vusion 140.000 € (+1,60 %)     COHERIS 11.850 € (-1,25 %)     TOTALENERGIES 67.150 € (+0,31 %)     WORLDLINE 10.232 € (-5,50 %)     LVMH 491.400 € (-0,87 %)     ARCELORMITTAL SA 56.960 € (-2,80 %)     COVIVIO HOTELS 22.200 € (-0,89 %)     ABN AMRO BANK N.V. 38.630 € (+0,99 %)     ACCOR 50.000 € (-1,77 %)     FIGEAC AERO 12.140 € (-0,33 %)     BE SEMICONDUCTOR 258.100 € (-5,49 %)     NEDAP 93.600 € (-2,60 %)     CIECHARGEURSINVEST 7.500 € (-1,96 %)     ORANGE 15.700 € (-1,01 %)     BENETEAU 6.230 € (-0,16 %)     VEOLIA ENVIRON. 37.080 € (-1,15 %)     NEXANS 141.200 € (-0,56 %)     AMUNDI 89.450 € (+2,46 %)     MAISON POMMERY 10.200 € (0,00 %)     DANONE 72.500 € (-1,23 %)     ALTEN 55.850 € (0,00 %)     L'OREAL 378.000 € (-1,16 %)     LUMIBIRD 26.900 € (+4,67 %)     ARCHOS 0.205 € (+4,66 %)     KAUFMAN ET BROAD 24.800 € (0,00 %)     TIKEHAU CAPITAL 17.420 € (+0,23 %)     PLANISWARE 21.600 € (-0,46 %)     ASR NEDERLAND 67.000 € (+0,66 %)     ACOMO 22.650 € (-0,44 %)     PROSUS 38.155 € (+3,14 %)     GTT 189.600 € (-0,05 %)     NX FILTRATION 3.505 € (-5,01 %)     AHOLD DEL 35.440 € (-1,34 %)     DSM FIRMENICH AG 83.320 € (-1,98 %)     CARREFOUR 15.920 € (-1,24 %)     WOLTERS KLUWER 57.880 € (+0,45 %)     EXAIL TECHNOLOGIES 125.100 € (+2,12 %)     TELEPERFORMANCE 50.600 € (-2,50 %)     ALFEN 14.550 € (-0,82 %)     CTP 16.860 € (-0,35 %)     BNP PARIBAS ACT.A 103.600 € (+0,90 %)     LHYFE 1.860 € (+0,43 %)     CEGEDIM 10.400 € (-1,33 %)     HEINEKEN 75.220 € (-1,39 %)     BOUYGUES 47.920 € (-0,85 %)     LAKEFRONT BIOTHER. 26.400 € (-1,86 %)     ADYEN 868.600 € (+0,73 %)     ABEO 9.600 € (+0,21 %)     AIR LIQUIDE 177.600 € (-1,50 %)     TKH GROUP 43.880 € (+0,14 %)     EURAZEO 41.960 € (+0,82 %)     SCHNEIDER ELECTRIC 278.350 € (-0,62 %)     ADP 116.900 € (+0,95 %)     VALERIO TX 0.430 € (-15,69 %)     RELX 28.020 € (+2,19 %)     SPIE 52.550 € (-0,38 %)     ASM INTERNATIONAL 964.400 € (-1,15 %)     ASML HOLDING 1 628.400 € (-0,37 %)     STMICROELECTRONICS 63.360 € (+0,92 %)     BUREAU VERITAS 27.280 € (+0,29 %)  
News Réglementées
06/07/2026 12:40

Form 8 (OPD)

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:SEGRO PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
SEGRO PLC
(d) Is the discloser the offeror or the offeree?OFFEREE
(e) Date position held:
The latest practicable date prior to the disclosure
6 JULY 2026
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state “N/A”
YES – PROLOGIS, INC.

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:Ordinary shares of 10 pence each
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:NIL-NIL-
(2) Cash-settled derivatives:NIL-NIL-
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:NIL-NIL-
 
TOTAL:
NIL-NIL-

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:NONE
Details, including nature of the rights concerned and relevant percentages:NONE

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:
  1. Interests held by directors of SEGRO plc and their close relatives and related trusts
NameNo. of ordinary sharesPercentage of total issued share capital*
Andrew Harrison564,7550.04%
Carol Ann Fairweather20,0000.00%
David John Rivers Sleath1,277,4990.09%
Dr. Linda Yi-Chuang Yueh4,716[1]0.00%
Marcus Sperber11,1370.00%
Mary Elizabeth Barnard12,50720.00%
Simon William David Fraser31,4400.00%
Susan Vivien Clayton8,01330.00%
Susanne Dorothee Schroeter1,9410.00%

* Figures are rounded down to two decimal places and are calculated on the basis of SEGRO plc having 1,354,073,367 ordinary shares of 10 pence each in issue (as set out in SEGRO plc's announcement dated 1 July 2026).
[1] 1,559 ordinary shares held by a close relative of Dr. Linda Yi-Chuang Yueh.
2 Held by a close relative of Mary Elizabeth Barnard.
3 1,013 ordinary shares held by a close relative of Susan Vivien Clayton.
  1. Interests held as options or awards under the share plans of SEGRO plc by the directors of SEGRO plc and their close relatives and related trusts
NameShare plan under which option or award was granted1No. of ordinary shares in SEGRO plc under option or subject to award1Date of grantExercise price (pence)Vesting date(s)2Expiry date
David John Rivers SleathLTIP264,00122 March 2024Nil22 March 2027-
335,37819 February 2025Nil19 February 2028-
304,18125 February 2026Nil25 February 2029-
Sharesave3,03515 April 2026599.521 June 20291 December 2029
Susanne Dorothee SchroeterLTIP128,3852 December 2025Nil19 February 2028-
105,51432 December 2025Nil31 March 2027; 31 March 2028-
169,58525 February 2026Nil25 February 2029-
Sharesave3,03515 April 2026599.521 June 20291 December 2029

[1] LTIP awards are structured as conditional awards over ordinary shares. Sharesave is an HMRC approved option scheme.

2 LTIP awards are subject to a three-year performance period followed by a two-year post-vesting holding period.

3 Granted as a recruitment LTIP award on Susanne Dorothee Schroeter's appointment as an executive director of
SEGRO plc, vesting in two equal tranches (50 per cent on 31 March 2027 and 50 per cent on 31 March 2028,
subject to continued employment) and not subject to performance conditions or a post-vesting holding period.
  1. Interests of connected advisers
NameNo. of ordinary sharesPercentage of total issued share capital
Calvert Research and Management1103,4740.008

[1] Calvert Research and Management is a group company of Morgan Stanley.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
 
None.

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”
 
None.

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)NO
Supplemental Form 8 (SBL)NO

 

Date of disclosure:6 July 2026
Contact name:Stephanie Murton
Telephone number:+44 207 451 9082

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière